Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sulcardine - HUYA Bioscience International

Next Previous
Drug Profile

Sulcardine - HUYA Bioscience International

Alternative Names: HBI-3000; HBI-3020; Sulcardine sulfate - HUYA Bioscience International; Sulcardine sulphate - HUYA Bioscience International

Latest Information Update: 02 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Furui Pharmaceuticals; Shanghai Institute of Materia Medica
  • Developer HUYA Bioscience International; Jiangsu Furui Pharmaceuticals
  • Class Antiarrhythmics; Benzene derivatives; Ethers; Pyrrolidines; Small molecules; Sulfonamides
  • Mechanism of Action Ion channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Atrial fibrillation
  • No development reported Arrhythmias

Most Recent Events

  • 24 Apr 2025 Efficacy and adverse event data from a phase II trial in Atrial fibrillation released by HUYA Bioscience International
  • 16 Nov 2024 Efficacy data from a phase II trial in Atrial fibrillation presented at the American Heart Association Scientific Sessions 2024 (AHA-2024)
  • 30 Aug 2024 Pharmacokinetics and safety data from a phase I drug-drug interaction trial presented at the Annual Congress of the European Society of Cardiology (ESC-Card-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top